http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150089426-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857808e8c34d8d82ffeb934e8fc45e14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725a7e395b1a006312591b7052d22b01
publicationDate 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20150089426-A
titleOfInvention Preparation of beta-glucan microspheres for drug delivery system
abstract The present invention relates to a method for preparing microspheres by using 1,3-β-glucan and supporting drugs on the microspheres to use the microspheres as a drug carrier. The β-glucan of a natural polymer is hydrolyzed to lower the molecular weight thereof, and a low molecular weighted β-glucan solution is cross-linked with water/organic solvent (w/o) type β-glucan microspheres prepared by an emulsification technique such that the surface of a particle becomes smooth, whereby β-glucan microspheres having a relatively uniform size can be prepared in a desired size. The drugs are mixed and cross-linked in an emulsion state to obtain drug-supported microspheres, and the drugs can be supported by preparing the β-glucan microspheres and putting the same into a drug aqueous solution. The particle of the β-glucan microspheres has low toxicity, biodegradability, and biocompatibility, thereby being suitable for use in health supplement food, cosmetics, or medicines.
priorityDate 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426254013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453272693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426276732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164181553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414876235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535

Total number of triples: 34.